Explore the top 3 Singapore blue-chip stocks hitting 52-week highs. Are they still buys for your investment portfolio?

Learn how 3 key dividend blue chips outperformed the STI in 2026, delivering stunning returns and solid dividend figures.

A US$22.4 billion order book provides strong revenue visibility, but investors should look beyond the headline figure.

Four mid-cap SGX stocks outperformed the STI in 3Q2026, but their cash flows reveal important differences beneath the strong ...

The Fed’s latest rate hike puts S-REITs back under the spotlight, but the pace of future increases may matter more than the final rate.

We take a closer look at three US-listed stocks that have doubled, at a minimum, over the past year. AMD’s stock price has ...

SGX investors will soon be able to access tax‑efficient S&P 500, NASDAQ-100 and MSCI World exposure directly in SGD.

October puts three Temasek-backed blue chips in focus after major moves involving Seatrium’s buyback, MLT’s asset sale and ...

Today, you will need far less money to buy into some of Singapore’s blue chips. As of 5 October 2026, the Singapore Exchange (SGX) has cut the standard board lot size for 11 securities from 100 shares ...

Explore 3 Temasek-backed blue-chips raising quarterly dividends by up to 25%. Discover investment opportunities now.

It was a good quarter to own Singapore blue chips. The SPDR STI ETF (SGX: ES3), which tracks the Straits Times Index (SGX: ...

Find out the details of the worst-performing SGX blue chips in Q3 2026. Evaluate if they present a bargain or a trap.